Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF MIDDLE EAST AND AFRICA RADIOFREQUENCY (RF) MICRONEEDLING MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 KEY TAKEAWAYS
2.2 ARRIVING AT THE MIDDLE EAST AND AFRICA RADIOFREQUENCY (RF) MICRONEEDLING MARKET SIZE
2.2.1 VENDOR POSITIONING GRID
2.2.2 TECHNOLOGY LIFE LINEE CURVE
2.2.3 TRIPOD DATA VALIDATION MODEL
2.2.4 MARKET GUIDE
2.2.5 MULTIVARIATE MODELLING
2.2.6 TOP TO BOTTOM ANALYSIS
2.2.7 CHALLENGE MATRIX
2.2.8 APPLICATION COVERAGE GRID
2.2.9 STANDARDS OF MEASUREMENT
2.2.10 VENDOR SHARE ANALYSIS
2.2.11 DATA POINTS FROM KEY PRIMARY INTERVIEWS
2.2.12 DATA POINTS FROM KEY SECONDARY DATABASES
2.3 MIDDLE EAST AND AFRICA RADIOFREQUENCY (RF) MICRONEEDLING MARKET: RESEARCH SNAPSHOT
2.4 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 CHALLENGES
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
5.1 PESTEL ANALYSIS
5.2 PORTER’S FIVE FORCES MODEL
6 INDUSTRY INSIGHTS
6.1 MICRO AND MACRO ECONOMIC FACTORS
6.2 PENETRATION AND GROWTH PROSPECT MAPPING
6.3 KEY PRICING STRATEGIES
6.4 INTERVIEWS WITH SPECIALIST
6.5 ANALYIS AND RECOMMENDATION
7 INTELLECTUAL PROPERTY (IP) PORTFOLIO
7.1 PATENT QUALITY AND STRENGTH
7.2 PATENT FAMILIES
7.3 LICENSING AND COLLABORATIONS
7.4 COMPETITIVE LANDSCAPE
7.5 IP STRATEGY AND MANAGEMENT
7.6 OTHER
8 COST ANALYSIS BREAKDOWN
9 TECHNONLOGY ROADMAP
10 INNOVATION TRACKER AND STRATEGIC ANALYSIS
10.1 MAJOR DEALS AND STRATEGIC ALLIANCES ANALYSIS
10.1.1 JOINT VENTURES
10.1.2 MERGERS AND ACQUISITIONS
10.1.3 LICENSING AND PARTNERSHIP
10.1.4 TECHNOLOGY COLLABORATIONS
10.1.5 STRATEGIC DIVESTMENTS
10.2 NUMBER OF PRODUCTS IN DEVELOPMENT
10.3 STAGE OF DEVELOPMENT
10.4 TIMELINES AND MILESTONES
10.5 INNOVATION STRATEGIES AND METHODOLOGIES
10.6 RISK ASSESSMENT AND MITIGATION
10.7 FUTURE OUTLOOK
11 REGULATORY COMPLIANCE
11.1 REGULATORY AUTHORITIES
11.2 REGULATORY CLASSIFICATIONS
11.2.1 CLASS I
11.2.2 CLASS II
11.2.3 CLASS III
11.3 REGULATORY SUBMISSIONS
11.4 INTERNATIONAL HARMONIZATION
11.5 COMPLIANCE AND QUALITY MANAGEMENT SYSTEMS
11.6 REGULATORY CHALLENGES AND STRATEGIES
12 REIMBURSEMENT FRAMEWORK
13 OPPUTUNITY MAP ANALYSIS
14 VALUE CHAIN ANALYSIS
15 HEALTHCARE ECONOMY
15.1 HEALTHCARE EXPENDITURE
15.2 CAPITAL EXPENDITURE
15.3 CAPEX TRENDS
15.4 CAPEX ALLOCATION
15.5 FUNDING SOURCES
15.6 INDUSTRY BENCHMARKS
15.7 GDP RATION IN OVERALL GDP
15.8 HEALTHCARE SYSTEM STRUCTURE
15.9 GOVERNMENT POLICIES
15.1 ECONOMIC DEVELOPMENT
16 MIDDLE EAST AND AFRICA RADIOFREQUENCY (RF) MICRONEEDLING MARKET, BY PRODUCT
16.1 OVERVIEW
16.2 DEVICES
16.2.1 SYSTEM
16.2.1.1. BY MODALITY
16.2.1.1.1. STANDALONE
16.2.1.1.2. PORTABLE
16.2.1.2. BY TYPE
16.2.1.2.1. FRACTIONAL
16.2.1.2.2. NON-FRACTIONAL
16.2.1.3. BY ENERGY TYPE
16.2.1.3.1. BIPOLAR
16.2.1.3.2. MONOPOLAR
16.2.1.3.3. OTHERS
16.2.1.4. BY ENERGY MODE
16.2.1.4.1. 0.5 MHZ
16.2.1.4.2. 1 MHZ
16.2.1.4.3. 2MHZ
16.2.1.5. BY MODES
16.2.1.5.1. L-MODE
16.2.1.5.2. F-MODE
16.2.1.5.3. B-MODE
16.2.2 HANDPIECES
16.2.2.1. BY MODE
16.2.2.1.1. SMART
16.2.2.1.2. DEEP
16.2.2.1.3. EXACT
16.2.2.2. BY TYPE
16.2.2.2.1. MOTORIZED HANDPIECE
16.2.2.2.2. AC HANDPIECE
16.2.2.2.3. OTHERS
16.2.3 OTHERS
16.3 RF MICRO NEEDLE SETS
16.3.1 BY DEPTH OF PENETRATION
16.3.1.1. SHALLOW
16.3.1.2. MEDIUM
16.3.1.3. DEEP
16.3.2 BY NEEDLE DEPTH
16.3.2.1. BELOW 0.5 MM
16.3.2.2. 0.5MM TO 3.5 MM
16.3.2.3. ABOVE 3.5 MM
16.3.3 BY NEEDLE TYPE
16.3.3.1. 9 NEEDLE
16.3.3.2. 16 NEEDLE
16.3.3.3. 21 NEEDLE
16.3.3.4. 25 NEEDLE
16.3.3.5. 49 NEEDLE
16.3.3.6. 81 NEEDLE
16.3.3.7. OTHERS
16.3.4 BY TIPE SIZE
16.3.4.1. SMALL TIP
16.3.4.2. FULL TIP
16.3.5 BY MATERIAL
16.3.5.1. SILICON
16.3.5.2. METALS
16.3.5.3. OTHERS
16.3.6 BY NEEDLE COVERING
16.3.6.1. INSULATED
16.3.6.1.1. SINGLE INSULATED
16.3.6.1.1.1 .08MM
16.3.6.1.1.2 .12MM
16.3.6.1.1.3 .15MM
16.3.6.1.1.4 OTHERS
16.3.6.1.2. MULTI INSULATED
16.3.6.1.2.1 .08MM
16.3.6.1.2.2 .12MM
16.3.6.1.2.3 .15MM
16.3.6.1.2.4 OTHERS
16.3.6.2. SEMI-INSULATED
16.3.6.3. NON INSULATED
16.3.7 OTHERS
17 MIDDLE EAST AND AFRICA RADIOFREQUENCY (RF) MICRONEEDLING MARKET, BY APPLICATION
17.1 OVERVIEW
17.2 ACNE SCAR
17.2.1 DEVICES
17.2.2 RF MICRONEEDLE SETS
17.3 INFLAMATORY ACENE
17.3.1 DEVICES
17.3.2 RF MICRONEEDLE SETS
17.4 FINE LINES
17.4.1 DEVICES
17.4.2 RF MICRONEEDLE SETS
17.5 ENLARGED PORES
17.5.1 DEVICES
17.5.2 RF MICRONEEDLE SETS
17.6 WRINKLES
17.6.1 FINE AND DEEP WRINKLES
17.6.1.1. DEVICES
17.6.1.2. RF MICRONEEDLE SETS
17.6.2 NASOLABIAL FOLDS
17.6.2.1. DEVICES
17.6.2.2. RF MICRONEEDLE SETS
17.7 SKIN TIGHTENING
17.7.1 DEVICES
17.7.2 RF MICRONEEDLE SETS
17.8 STRETCH MARKS
17.8.1 DEVICES
17.8.2 RF MICRONEEDLE SETS
17.9 HYPERPIGMENTATION
17.9.1 DEVICES
17.9.2 RF MICRONEEDLE SETS
17.1 IRREGULAR SKIN TEXTURE
17.10.1 DEVICES
17.10.2 RF MICRONEEDLE SETS
17.11 TONE
17.11.1 DEVICES
17.11.2 RF MICRONEEDLE SETS
17.12 FACE LIFTING
17.12.1 DEVICES
17.12.2 RF MICRONEEDLE SETS
17.13 ELASTICITY AND SKIN REGENERATION
17.13.1 DEVICES
17.13.2 RF MICRONEEDLE SETS
17.14 OTHERS
17.14.1 NECK
17.14.2 EYEBAGS
17.14.3 JAWLINE AREAS
17.14.4 FESTOONS AND BUCCAL
17.14.5 PERIORBITAL AND SUBMENTAL AREAS
17.14.6 SCARS FROM INJURY OR SURGERY
17.14.7 LOOSE AND SAGGING SKIN
17.14.8 HYPERHIDROSIS
17.14.9 CELLULITE
18 MIDDLE EAST AND AFRICA RADIOFREQUENCY (RF) MICRONEEDLING MARKET, BY GENDER
18.1 OVERVIEW
18.2 MALE
18.3 FEMALE
19 MIDDLE EAST AND AFRICA RADIOFREQUENCY (RF) MICRONEEDLING MARKET, BY END USER
19.1 OVERVIEW
19.2 HOSPITALS
19.2.1 PRIVATE
19.2.1.1. TIER 1
19.2.1.2. TIER 2
19.2.1.3. TIER 3
19.2.2 PUBLIC
19.2.2.1. TIER 1
19.2.2.2. TIER 2
19.2.2.3. TIER 3
19.3 DERMATOLOGY CLINICS
19.4 SPECIALTY CLINICS
19.5 AMBULATORY CARE CENTERS
19.6 MEDICAL SPAS
19.7 OTHERS
20 MIDDLE EAST AND AFRICA RADIOFREQUENCY (RF) MICRONEEDLING MARKET, BY DISTRIBUTION CHANNEL
20.1 OVERVIEW
20.2 DIRECT TENDER
20.3 RETAIL SALES
20.3.1 ONLINE SALES
20.3.2 OFFLINE SALES
20.4 OTHERS
21 MIDDLE EAST AND AFRICA RADIOFREQUENCY (RF) MICRONEEDLING MARKET, SWOT AND DBMR ANALYSIS
22 MIDDLE EAST AND AFRICA RADIOFREQUENCY (RF) MICRONEEDLING MARKET, COMPANY LANDSCAPE
22.1 COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA
22.2 MERGERS & ACQUISITIONS
22.3 NEW PRODUCT DEVELOPMENT & APPROVALS
22.4 EXPANSIONS
22.5 REGULATORY CHANGES
22.6 PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
23 MIDDLE EAST AND AFRICA RADIOFREQUENCY (RF) MICRONEEDLING MARKET, BY REGION
MIDDLE EAST AND AFRICA RADIOFREQUENCY (RF) MICRONEEDLING MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
23.1 MIDDLE EAST AND AFRICA
23.1.1 SOUTH AFRICA
23.1.2 EGYPT
23.1.3 BAHRAIN
23.1.4 UNITED ARAB EMIRATES
23.1.5 KUWAIT
23.1.6 OMAN
23.1.7 QATAR
23.1.8 SAUDI ARABIA
23.1.9 REST OF MEA
23.2 KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
24 MIDDLE EAST AND AFRICA RADIOFREQUENCY (RF) MICRONEEDLING MARKET, COMPANY PROFILE
24.1 BIONICS MEDICAL TRADING LLC
24.1.1 COMPANY OVERVIEW
24.1.2 REVENUE ANALYSIS
24.1.3 GEOGRAPHIC PRESENCE
24.1.4 PRODUCT PORTFOLIO
24.1.5 RECENT DEVELOPMENTS
24.2 LUMENIS BE LTD.
24.2.1 COMPANY OVERVIEW
24.2.2 REVENUE ANALYSIS
24.2.3 GEOGRAPHIC PRESENCE
24.2.4 PRODUCT PORTFOLIO
24.2.5 RECENT DEVELOPMENTS
24.3 CUTERA INC.
24.3.1 COMPANY OVERVIEW
24.3.2 REVENUE ANALYSIS
24.3.3 GEOGRAPHIC PRESENCE
24.3.4 PRODUCT PORTFOLIO
24.3.5 RECENT DEVELOPMENTS
24.4 CYNOSURE LUTRONIC
24.4.1 COMPANY OVERVIEW
24.4.2 REVENUE ANALYSIS
24.4.3 GEOGRAPHIC PRESENCE
24.4.4 PRODUCT PORTFOLIO
24.4.5 RECENT DEVELOPMENTS
24.5 CANDELA CORPORATION
24.5.1 COMPANY OVERVIEW
24.5.2 REVENUE ANALYSIS
24.5.3 GEOGRAPHIC PRESENCE
24.5.4 PRODUCT PORTFOLIO
24.5.5 RECENT DEVELOPMENTS
24.6 ENDYMED
24.6.1 COMPANY OVERVIEW
24.6.2 REVENUE ANALYSIS
24.6.3 GEOGRAPHIC PRESENCE
24.6.4 PRODUCT PORTFOLIO
24.6.5 RECENT DEVELOPMENTS
24.7 AGNES MEDICAL CO.,LTD.
24.7.1 COMPANY OVERVIEW
24.7.2 REVENUE ANALYSIS
24.7.3 GEOGRAPHIC PRESENCE
24.7.4 PRODUCT PORTFOLIO
24.7.5 RECENT DEVELOPMENTS
24.8 VIOL CO., LTD.
24.8.1 COMPANY OVERVIEW
24.8.2 REVENUE ANALYSIS
24.8.3 GEOGRAPHIC PRESENCE
24.8.4 PRODUCT PORTFOLIO
24.8.5 RECENT DEVELOPMENTS
24.9 SHENB
24.9.1 COMPANY OVERVIEW
24.9.2 REVENUE ANALYSIS
24.9.3 GEOGRAPHIC PRESENCE
24.9.4 PRODUCT PORTFOLIO
24.9.5 RECENT DEVELOPMENTS
24.1 JEISYS MEDICAL INC.
24.10.1 COMPANY OVERVIEW
24.10.2 REVENUE ANALYSIS
24.10.3 GEOGRAPHIC PRESENCE
24.10.4 PRODUCT PORTFOLIO
24.10.5 RECENT DEVELOPMENTS
24.11 AESTHETICS BIOMEDICAL INC.
24.11.1 COMPANY OVERVIEW
24.11.2 REVENUE ANALYSIS
24.11.3 GEOGRAPHIC PRESENCE
24.11.4 PRODUCT PORTFOLIO
24.11.5 RECENT DEVELOPMENTS
24.12 SINCOHEREN LTD
24.12.1 COMPANY OVERVIEW
24.12.2 REVENUE ANALYSIS
24.12.3 GEOGRAPHIC PRESENCE
24.12.4 PRODUCT PORTFOLIO
24.12.5 RECENT DEVELOPMENTS
24.13 LYNTON LASERS LTD
24.13.1 COMPANY OVERVIEW
24.13.2 REVENUE ANALYSIS
24.13.3 GEOGRAPHIC PRESENCE
24.13.4 PRODUCT PORTFOLIO
24.13.5 RECENT DEVELOPMENTS
24.14 HIRONIC CO., LTD.
24.14.1 COMPANY OVERVIEW
24.14.2 REVENUE ANALYSIS
24.14.3 GEOGRAPHIC PRESENCE
24.14.4 PRODUCT PORTFOLIO
24.14.5 RECENT DEVELOPMENTS
24.15 NUBWAY
24.15.1 COMPANY OVERVIEW
24.15.2 REVENUE ANALYSIS
24.15.3 GEOGRAPHIC PRESENCE
24.15.4 PRODUCT PORTFOLIO
24.15.5 RECENT DEVELOPMENTS
24.16 SANHE BEAUTY S & T CO.,LTD
24.16.1 COMPANY OVERVIEW
24.16.2 REVENUE ANALYSIS
24.16.3 GEOGRAPHIC PRESENCE
24.16.4 PRODUCT PORTFOLIO
24.16.5 RECENT DEVELOPMENTS
24.17 SHENZHEN GSD TECH CO., LTD.
24.17.1 COMPANY OVERVIEW
24.17.2 REVENUE ANALYSIS
24.17.3 GEOGRAPHIC PRESENCE
24.17.4 PRODUCT PORTFOLIO
24.17.5 RECENT DEVELOPMENTS
25 RELATED REPORTS
26 CONCLUSION
27 QUESTIONNAIRE
28 ABOUT DATA BRIDGE MARKET RESEARCH
